Heparin is more effective than inogatran, a low-molecular weight thrombin inhibitor in suppressing ischemia and recurrent angina in unstable coronary disease

American Journal of Cardiology

Volumn 81, Issue 8, 1998, Pages 939-944

  Andersen, Karl ^a,b   Dellborg, Mikael ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b Sjúkrahús Reykjavíkur ^*  (Iceland)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; INOGATRAN; THROMBIN INHIBITOR;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE CONTROL; ELECTROCARDIOGRAM; HEART MUSCLE ISCHEMIA; HOLTER MONITORING; HOSPITAL ADMISSION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; PATIENT MONITORING; PRIORITY JOURNAL; Q WAVE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; ST SEGMENT; THORAX PAIN; VECTORCARDIOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; ANGINA, UNSTABLE; ANTICOAGULANTS; ANTITHROMBINS; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; FOLLOW-UP STUDIES; GLYCINE; HEPARIN; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PIPERIDINES; PROSPECTIVE STUDIES; RECURRENCE; THROMBIN; VECTORCARDIOGRAPHY;

EID: 0032522549     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00069-1     Document Type: Article

References (23)

1. Bugiardini R, Borghi A, Pozzati A, Rugged A, Puddu P, Maseri A. Relation of severity of symptoms to transient myocardial ischemia and prognosis in unstable angina. J Am Coll Cardiol 1995;25:597-604.
2. Gill JB, Cairns JA, Roberts RS, Tech M, Constantini L, Sealy BJ, Fallen EF, Tomlinson CW, Gent M. Prognostic importance of myocardial ischemia detected by ambulatory monitoring early after acute myocardial infarction. N Engl J Med 1996;334:65-70.
3. Gottlieb SO, Weisfeldt ML, Ouyang P, Mellits ED, Gerstenblith G. Silent ischaemia as a marker for early unfavorable outcome in patients with unstable angina. N Engl J Med 1986;314:1214-1219.
4. Johnson SM, Mauritson DR, Winniford MD, Willerson JT, Firth BG, Cary JR, Hillis LD. Continuous electro cardiographie monitoring in patients with unstable angina pectoris: identification of high-risk subgroup with severe coronary disease, variant angina, and/or impaired early prognosis. Am Heart J 1982;103:4-12.
5. Nademanee K, Intarachot V, Josephson MA, Rieders D, Mody FV, Singh BN. Prognostic significance of silent myocardial ischemia in patients with unstable angina. J Am Coll Cardiol 1987;10:1-9.
6. Patel DJ, Holdright DR, Knight CJ, Mulcahy D, Thakrar B, Wright C, Sparrow J, Wicks M, Hubbard W, Thomas R, Sutton GC, Hendry G, Purcell H, Fox K. Early continuous ST segment monitoring in unstable angina: prognostic value additional to the clinical characteristics and the admission electrocardiogram. Heart 1996;75:222-228.
7. Pepine CJ. Prognostic implications of silent myocardial ischemia. N Engl J Med 1996;334:113-114.
8. Wilcox I, Freedman SB, Kelly DT, Harris PJ. Clinical significance of silent ischemia in unstable angina pectoris. Am J Cardiol 1990;65:1313-1316.
9. Dellborg M, Malmberg K, Rydén L, Svensson A-M, Swedberg K. Dynamic on-line vectorcardiography improves and simplifies in hospital ischemia monitoring of patients with unstable angina. J Am Coll Cardiol 1995;26:1501-1507.
10. Lundin P, Eriksson SV, Fredrikson M, Rehnqvist N. Prognostic information from on-line vectorcardiography in unstable angina pectoris. Cardiology 1995;86:60-66.
11. Andersen K, Eriksson P, Dellborg M. Non-invasive risk stratification within 48 hours of hospital admission in patients with unstable coronary disease. Eur Heart J 1997;18:780-788.
12. Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Circulation 1985;71:699-708.
13. Jensen SM, Johansson G, Osterman G, Reiz S, Näslund U. On-line computerized vectorcardiography monitoring of myocardial ischemia during coronary angioplasty: comparison with 12-lead electrocardiography. Coron Art Dis 1994; 5:507-514.
14. Klootwijk P, Meij S, Es GAv, Müller EJ, Umans VAWM, Lenderink T, Simoons ML. Comparison of usefulness of computer assisted continuous 48-h 3-lead with 12-lead ECG ischaemia monitoring for detection and quantitation of ischaemia in patients with unstable angina. Eur Heart J 1997;18:931-940.
15. Rihal CS, Flather M, Hirsh J, Yusuf S. Advances in antithrombotic drug therapy for coronary artery disease. Eur Heart J 1995;16(suppl D):10-21.
16. Chesebro JH, Webster MWI, Zoldhelyi P, Roche PC, Badimon L, Badimon JJ. Antithrombotic therapy and progression of coronary artery disease. Antiplatelets versus antithrombins. Circulation 1992;86:III-100-III-111.
17. Andersen K, Dellborg M, Emanuelsson H, Grip L, Swedberg K. Thrombin inhibition with inogatran for unstable angina pectoris: evidence for reactivated ischaemia after cessation of short-term treatment. Coron Art Dis 1996;7:673-681.
18. Dellborg M, Gustavsson G, Riha M, Swedberg K. Dynamic changes of the QRS-complex in unstable angina pectoris. Int J Cardiol 1992;36:151-162.
19. Andersen K, Eriksson P, Dellborg M. Ischaemia detected by continuous on-line vectorcardiographic monitoring predicts unfavourable outcome in patients admitted with probable unstable coronary disease. Coron Art Dis 1996;7: 753-760.
20. Langer A, Freeman MR, Armstrong PW. ST segment shift in unstable angina: pathophysiology and association with coronary anatomy and hospital outcome. J Am Coll Cardiol 1989;13:1495-1502.
21. TRIM Study Group. A low molecular weight, specific thrombin inhibitor, inogatran, versus heparin, in unstable coronary artery disease in 1209 patients: a double blind, randomised dose finding study. Eur Heart J 1997;18:1416-1425.
22. The GUSTO lib Investigators. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. N Engl J Med 1996;225: 775-782.
23. FRISC Study Group. Low-molecular-weight heparin during instability in coronary artery disease. Lancet 1996;347:561-568.